A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors

Clinical trial NCT06010875 · RECRUITING

Trial details

NCT number: NCT06010875
Sponsor: Chongqing Precision Biotech Co., Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Renal Cell Carcinoma Ovarian Cancer Cervix Cancer Metastatic Cancer Advanced Cancer

Start date: 2023-11-30
Primary completion: 2025-12-31
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.